Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Észtország

2 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  Where

  Tallinn, Tartu

  Életkor

  40 év to 80 év

  People

  942 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07190209 · EU 2024-518016-39-00
• 3. fázisCsak meghívásos
  Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency

  Where

  Tallinn

  Életkor

  20 év to 72 év

  People

  290 worldwide

  Run by

  Grifols Therapeutics LLC

  See details and how to joinNCT02796937